Valinor Pharma is focused on innovative commercialization of medicines that not only bring meaningful benefit to patients but also ensure that when a healthcare provider prescribes them to the patients they serve, their patients are able to get them easily and affordably.
To learn more about Valinor, our products, or to discuss partnership opportunities, please visit www.valinorrx.com.
Company Details
- Employees
- 34
- Address
- Chicago, Il 60606, Us
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.valinorrx.com
- Keywords
- Chicago.
- HQ
- Chicago, IL
Valinor Pharma (Acquired By Grünenthal) Questions
Valinor Pharma (Acquired By Grünenthal)'s website is http://www.valinorrx.com
Valinor Pharma (Acquired By Grünenthal)'s LinkedIn profile is https://www.linkedin.com/company/valinor-pharma
Valinor Pharma (Acquired By Grünenthal) has
34 employees.
View email and phone details for 34
employees at Valinor Pharma (Acquired By Grünenthal).
Valinor Pharma (Acquired By Grünenthal)'s industry is
Pharmaceutical Manufacturing
Valinor Pharma (Acquired By Grünenthal)'s top competitors are
Valinor,
Grunenthal Usa, Inc.,
Novos Growth Partners,
Astrazeneca,
Apollo Care,
Redhill Biopharma Ltd.,
Corium,
Averitas Pharma,
Grünenthal Group,
Valinor.
Valinor Pharma (Acquired By Grünenthal)'s categories are Pharmaceutical Manufacturing
